Clinical Trial: Wireless Implantable Mandarin Chinese Speech Neuroprosthesis Evaluation

U.S., June 16 -- ClinicalTrials.gov registry received information related to the study (NCT07647315) titled 'Wireless Implantable Mandarin Chinese Speech Neuroprosthesis Evaluation' on June 09.

Brief Summary: This prospective, single-arm clinical trial is designed to preliminarily evaluate the safety and efficacy of an implantable wireless brain-computer interface (BCI) system (manufactured by Shanghai StairMed Technology Co., Ltd.) in enabling subjects with speech disorders to achieve brain-controlled interaction and communication. Eligible subjects will undergo surgical implantation of the device and receive brain-control training. All participants will be followed for an expected period of 12 months. During the follow-up, adverse events...